Mitral regurgitation in patients with advanced systolic heart failure

Mitral regurgitation (MR) may develop in patients with advanced systolic congestive heart failure (CHF) without organic mitral valve disease and contribute to worsening symptoms and survival. Surgical mitral annuloplasty improves symptoms in patients with advanced CHF, and percutaneous approaches to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiac failure 2004-08, Vol.10 (4), p.285-291
Hauptverfasser: Patel, Jeetendra B, Borgeson, Daniel D, Barnes, Marion E, Rihal, Charanjit S, Daly, Richard C, Redfield, Margaret M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 291
container_issue 4
container_start_page 285
container_title Journal of cardiac failure
container_volume 10
creator Patel, Jeetendra B
Borgeson, Daniel D
Barnes, Marion E
Rihal, Charanjit S
Daly, Richard C
Redfield, Margaret M
description Mitral regurgitation (MR) may develop in patients with advanced systolic congestive heart failure (CHF) without organic mitral valve disease and contribute to worsening symptoms and survival. Surgical mitral annuloplasty improves symptoms in patients with advanced CHF, and percutaneous approaches to mitral annuloplasty are being developed. Our objective was to define the prevalence, clinical correlates, and prognostic implications of functional MR and the use of mitral annuloplasty in patients with advanced systolic CHF evaluated in a heart failure clinic. We reviewed clinical, echocardiographic, and survival data from all patients with advanced systolic CHF (New York Heart Association class III or IV; ejection fraction ≤35%) resulting from ischemic or idiopathic cardiomyopathy who were evaluated at our heart failure clinic between January 1996 and September 2001. Of 716 patients with advanced CHF, 558 had satisfactory baseline echocardiograms performed at our institution. Among these patients, MR was severe in 24 (4.3%), moderate-severe in 70 (12.5%), moderate in 122 (21.9%), mild-moderate in 66 (11.8%), mild in 218 (39.1%), and absent or present as only a trace in 58 (10.4%). The severity of MR was confirmed by quantitative analysis in 72% of patients with hemodynamically significant MR (more than moderate). The severity of MR correlated with the severity of systolic dysfunction ( P < .001), ventricular dilatation ( P
doi_str_mv 10.1016/j.cardfail.2003.12.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66784163</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S107191640300808X</els_id><sourcerecordid>66784163</sourcerecordid><originalsourceid>FETCH-LOGICAL-c364t-23c572d0d9b7f01abc5ab39650640c3561130c426458d1cbcb1fe5ecf328a923</originalsourceid><addsrcrecordid>eNqFkLtOwzAUhi0EolB4hcoTW8LxJU6zgapykYpYuluO7bSu0qTYTlHfHlctYmQ6Z_j-c_kQmhDICRDxuMm18qZRrs0pAMsJzQHEBbohBaPZlBN-mXooSVYRwUfoNoQNAEw5lNdolCCoRMVu0PzDRa9a7O1q8CsXVXR9h12Hd6mzXQz428U1VmavOm0NDocQ-9ZpvLbKR3w8YPD2Dl01qg32_lzHaPkyX87essXn6_vseZFpJnjMKNNFSQ2Yqi4bIKrWhapZJQoQHDQrBCEMNKeCF1NDdK1r0tjC6obRqaooG6OH09id778GG6LcuqBt26rO9kOQQpTpc8ESKE6g9n0I3jZy591W-YMkII_-5Eb--pNHf5JQmfyl4OS8Yai31vzFzsIS8HQCbHpz76yXQSdPSY3zVkdpevffjh8elYT1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66784163</pqid></control><display><type>article</type><title>Mitral regurgitation in patients with advanced systolic heart failure</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Patel, Jeetendra B ; Borgeson, Daniel D ; Barnes, Marion E ; Rihal, Charanjit S ; Daly, Richard C ; Redfield, Margaret M</creator><creatorcontrib>Patel, Jeetendra B ; Borgeson, Daniel D ; Barnes, Marion E ; Rihal, Charanjit S ; Daly, Richard C ; Redfield, Margaret M</creatorcontrib><description>Mitral regurgitation (MR) may develop in patients with advanced systolic congestive heart failure (CHF) without organic mitral valve disease and contribute to worsening symptoms and survival. Surgical mitral annuloplasty improves symptoms in patients with advanced CHF, and percutaneous approaches to mitral annuloplasty are being developed. Our objective was to define the prevalence, clinical correlates, and prognostic implications of functional MR and the use of mitral annuloplasty in patients with advanced systolic CHF evaluated in a heart failure clinic. We reviewed clinical, echocardiographic, and survival data from all patients with advanced systolic CHF (New York Heart Association class III or IV; ejection fraction ≤35%) resulting from ischemic or idiopathic cardiomyopathy who were evaluated at our heart failure clinic between January 1996 and September 2001. Of 716 patients with advanced CHF, 558 had satisfactory baseline echocardiograms performed at our institution. Among these patients, MR was severe in 24 (4.3%), moderate-severe in 70 (12.5%), moderate in 122 (21.9%), mild-moderate in 66 (11.8%), mild in 218 (39.1%), and absent or present as only a trace in 58 (10.4%). The severity of MR was confirmed by quantitative analysis in 72% of patients with hemodynamically significant MR (more than moderate). The severity of MR correlated with the severity of systolic dysfunction ( P &lt; .001), ventricular dilatation ( P &lt;.03), atrial dilatation ( P &lt; .001), diastolic dysfunction ( P &lt; .001), and pulmonary hypertension ( P &lt; .001). Coexistent severe or moderate-severe tricuspid regurgitation was present in 25% of patients with hemodynamically significant MR. Patients with hemodynamically significant MR had higher mortality ( P = .03) but not when controlling for age, sex, cause, New York Heart Association class, and ejection fraction ( P = .95). Only 3 patients subsequently underwent mitral valve repair. Among patients with advanced CHF, hemodynamically significant MR is common. The severity of MR did not provide independent prognostic information in this group recognized to have uniformly high mortality.</description><identifier>ISSN: 1071-9164</identifier><identifier>EISSN: 1532-8414</identifier><identifier>DOI: 10.1016/j.cardfail.2003.12.006</identifier><identifier>PMID: 15309693</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Aged, 80 and over ; Congestive heart failure ; Echocardiography ; Female ; Heart Failure - diagnostic imaging ; Heart Failure - mortality ; Heart Failure - physiopathology ; Humans ; Male ; Middle Aged ; Mitral Valve Insufficiency - diagnostic imaging ; Mitral Valve Insufficiency - mortality ; Mitral Valve Insufficiency - physiopathology ; Multivariate Analysis ; Predictive Value of Tests ; Prognosis ; Severity of Illness Index ; Statistics as Topic ; Stroke Volume - physiology ; Survival Analysis ; Systole - physiology ; Tricuspid valve regurgitation ; Ventricular Dysfunction - diagnostic imaging ; Ventricular Dysfunction - mortality ; Ventricular Dysfunction - physiopathology</subject><ispartof>Journal of cardiac failure, 2004-08, Vol.10 (4), p.285-291</ispartof><rights>2004 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c364t-23c572d0d9b7f01abc5ab39650640c3561130c426458d1cbcb1fe5ecf328a923</citedby><cites>FETCH-LOGICAL-c364t-23c572d0d9b7f01abc5ab39650640c3561130c426458d1cbcb1fe5ecf328a923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S107191640300808X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15309693$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Patel, Jeetendra B</creatorcontrib><creatorcontrib>Borgeson, Daniel D</creatorcontrib><creatorcontrib>Barnes, Marion E</creatorcontrib><creatorcontrib>Rihal, Charanjit S</creatorcontrib><creatorcontrib>Daly, Richard C</creatorcontrib><creatorcontrib>Redfield, Margaret M</creatorcontrib><title>Mitral regurgitation in patients with advanced systolic heart failure</title><title>Journal of cardiac failure</title><addtitle>J Card Fail</addtitle><description>Mitral regurgitation (MR) may develop in patients with advanced systolic congestive heart failure (CHF) without organic mitral valve disease and contribute to worsening symptoms and survival. Surgical mitral annuloplasty improves symptoms in patients with advanced CHF, and percutaneous approaches to mitral annuloplasty are being developed. Our objective was to define the prevalence, clinical correlates, and prognostic implications of functional MR and the use of mitral annuloplasty in patients with advanced systolic CHF evaluated in a heart failure clinic. We reviewed clinical, echocardiographic, and survival data from all patients with advanced systolic CHF (New York Heart Association class III or IV; ejection fraction ≤35%) resulting from ischemic or idiopathic cardiomyopathy who were evaluated at our heart failure clinic between January 1996 and September 2001. Of 716 patients with advanced CHF, 558 had satisfactory baseline echocardiograms performed at our institution. Among these patients, MR was severe in 24 (4.3%), moderate-severe in 70 (12.5%), moderate in 122 (21.9%), mild-moderate in 66 (11.8%), mild in 218 (39.1%), and absent or present as only a trace in 58 (10.4%). The severity of MR was confirmed by quantitative analysis in 72% of patients with hemodynamically significant MR (more than moderate). The severity of MR correlated with the severity of systolic dysfunction ( P &lt; .001), ventricular dilatation ( P &lt;.03), atrial dilatation ( P &lt; .001), diastolic dysfunction ( P &lt; .001), and pulmonary hypertension ( P &lt; .001). Coexistent severe or moderate-severe tricuspid regurgitation was present in 25% of patients with hemodynamically significant MR. Patients with hemodynamically significant MR had higher mortality ( P = .03) but not when controlling for age, sex, cause, New York Heart Association class, and ejection fraction ( P = .95). Only 3 patients subsequently underwent mitral valve repair. Among patients with advanced CHF, hemodynamically significant MR is common. The severity of MR did not provide independent prognostic information in this group recognized to have uniformly high mortality.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Congestive heart failure</subject><subject>Echocardiography</subject><subject>Female</subject><subject>Heart Failure - diagnostic imaging</subject><subject>Heart Failure - mortality</subject><subject>Heart Failure - physiopathology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mitral Valve Insufficiency - diagnostic imaging</subject><subject>Mitral Valve Insufficiency - mortality</subject><subject>Mitral Valve Insufficiency - physiopathology</subject><subject>Multivariate Analysis</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Severity of Illness Index</subject><subject>Statistics as Topic</subject><subject>Stroke Volume - physiology</subject><subject>Survival Analysis</subject><subject>Systole - physiology</subject><subject>Tricuspid valve regurgitation</subject><subject>Ventricular Dysfunction - diagnostic imaging</subject><subject>Ventricular Dysfunction - mortality</subject><subject>Ventricular Dysfunction - physiopathology</subject><issn>1071-9164</issn><issn>1532-8414</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkLtOwzAUhi0EolB4hcoTW8LxJU6zgapykYpYuluO7bSu0qTYTlHfHlctYmQ6Z_j-c_kQmhDICRDxuMm18qZRrs0pAMsJzQHEBbohBaPZlBN-mXooSVYRwUfoNoQNAEw5lNdolCCoRMVu0PzDRa9a7O1q8CsXVXR9h12Hd6mzXQz428U1VmavOm0NDocQ-9ZpvLbKR3w8YPD2Dl01qg32_lzHaPkyX87essXn6_vseZFpJnjMKNNFSQ2Yqi4bIKrWhapZJQoQHDQrBCEMNKeCF1NDdK1r0tjC6obRqaooG6OH09id778GG6LcuqBt26rO9kOQQpTpc8ESKE6g9n0I3jZy591W-YMkII_-5Eb--pNHf5JQmfyl4OS8Yai31vzFzsIS8HQCbHpz76yXQSdPSY3zVkdpevffjh8elYT1</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Patel, Jeetendra B</creator><creator>Borgeson, Daniel D</creator><creator>Barnes, Marion E</creator><creator>Rihal, Charanjit S</creator><creator>Daly, Richard C</creator><creator>Redfield, Margaret M</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040801</creationdate><title>Mitral regurgitation in patients with advanced systolic heart failure</title><author>Patel, Jeetendra B ; Borgeson, Daniel D ; Barnes, Marion E ; Rihal, Charanjit S ; Daly, Richard C ; Redfield, Margaret M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c364t-23c572d0d9b7f01abc5ab39650640c3561130c426458d1cbcb1fe5ecf328a923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Congestive heart failure</topic><topic>Echocardiography</topic><topic>Female</topic><topic>Heart Failure - diagnostic imaging</topic><topic>Heart Failure - mortality</topic><topic>Heart Failure - physiopathology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mitral Valve Insufficiency - diagnostic imaging</topic><topic>Mitral Valve Insufficiency - mortality</topic><topic>Mitral Valve Insufficiency - physiopathology</topic><topic>Multivariate Analysis</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Severity of Illness Index</topic><topic>Statistics as Topic</topic><topic>Stroke Volume - physiology</topic><topic>Survival Analysis</topic><topic>Systole - physiology</topic><topic>Tricuspid valve regurgitation</topic><topic>Ventricular Dysfunction - diagnostic imaging</topic><topic>Ventricular Dysfunction - mortality</topic><topic>Ventricular Dysfunction - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Patel, Jeetendra B</creatorcontrib><creatorcontrib>Borgeson, Daniel D</creatorcontrib><creatorcontrib>Barnes, Marion E</creatorcontrib><creatorcontrib>Rihal, Charanjit S</creatorcontrib><creatorcontrib>Daly, Richard C</creatorcontrib><creatorcontrib>Redfield, Margaret M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiac failure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Patel, Jeetendra B</au><au>Borgeson, Daniel D</au><au>Barnes, Marion E</au><au>Rihal, Charanjit S</au><au>Daly, Richard C</au><au>Redfield, Margaret M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitral regurgitation in patients with advanced systolic heart failure</atitle><jtitle>Journal of cardiac failure</jtitle><addtitle>J Card Fail</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>10</volume><issue>4</issue><spage>285</spage><epage>291</epage><pages>285-291</pages><issn>1071-9164</issn><eissn>1532-8414</eissn><abstract>Mitral regurgitation (MR) may develop in patients with advanced systolic congestive heart failure (CHF) without organic mitral valve disease and contribute to worsening symptoms and survival. Surgical mitral annuloplasty improves symptoms in patients with advanced CHF, and percutaneous approaches to mitral annuloplasty are being developed. Our objective was to define the prevalence, clinical correlates, and prognostic implications of functional MR and the use of mitral annuloplasty in patients with advanced systolic CHF evaluated in a heart failure clinic. We reviewed clinical, echocardiographic, and survival data from all patients with advanced systolic CHF (New York Heart Association class III or IV; ejection fraction ≤35%) resulting from ischemic or idiopathic cardiomyopathy who were evaluated at our heart failure clinic between January 1996 and September 2001. Of 716 patients with advanced CHF, 558 had satisfactory baseline echocardiograms performed at our institution. Among these patients, MR was severe in 24 (4.3%), moderate-severe in 70 (12.5%), moderate in 122 (21.9%), mild-moderate in 66 (11.8%), mild in 218 (39.1%), and absent or present as only a trace in 58 (10.4%). The severity of MR was confirmed by quantitative analysis in 72% of patients with hemodynamically significant MR (more than moderate). The severity of MR correlated with the severity of systolic dysfunction ( P &lt; .001), ventricular dilatation ( P &lt;.03), atrial dilatation ( P &lt; .001), diastolic dysfunction ( P &lt; .001), and pulmonary hypertension ( P &lt; .001). Coexistent severe or moderate-severe tricuspid regurgitation was present in 25% of patients with hemodynamically significant MR. Patients with hemodynamically significant MR had higher mortality ( P = .03) but not when controlling for age, sex, cause, New York Heart Association class, and ejection fraction ( P = .95). Only 3 patients subsequently underwent mitral valve repair. Among patients with advanced CHF, hemodynamically significant MR is common. The severity of MR did not provide independent prognostic information in this group recognized to have uniformly high mortality.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15309693</pmid><doi>10.1016/j.cardfail.2003.12.006</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1071-9164
ispartof Journal of cardiac failure, 2004-08, Vol.10 (4), p.285-291
issn 1071-9164
1532-8414
language eng
recordid cdi_proquest_miscellaneous_66784163
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aged
Aged, 80 and over
Congestive heart failure
Echocardiography
Female
Heart Failure - diagnostic imaging
Heart Failure - mortality
Heart Failure - physiopathology
Humans
Male
Middle Aged
Mitral Valve Insufficiency - diagnostic imaging
Mitral Valve Insufficiency - mortality
Mitral Valve Insufficiency - physiopathology
Multivariate Analysis
Predictive Value of Tests
Prognosis
Severity of Illness Index
Statistics as Topic
Stroke Volume - physiology
Survival Analysis
Systole - physiology
Tricuspid valve regurgitation
Ventricular Dysfunction - diagnostic imaging
Ventricular Dysfunction - mortality
Ventricular Dysfunction - physiopathology
title Mitral regurgitation in patients with advanced systolic heart failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T01%3A54%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitral%20regurgitation%20in%20patients%20with%20advanced%20systolic%20heart%20failure&rft.jtitle=Journal%20of%20cardiac%20failure&rft.au=Patel,%20Jeetendra%20B&rft.date=2004-08-01&rft.volume=10&rft.issue=4&rft.spage=285&rft.epage=291&rft.pages=285-291&rft.issn=1071-9164&rft.eissn=1532-8414&rft_id=info:doi/10.1016/j.cardfail.2003.12.006&rft_dat=%3Cproquest_cross%3E66784163%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66784163&rft_id=info:pmid/15309693&rft_els_id=S107191640300808X&rfr_iscdi=true